Response to: Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease"

Affiliations

¹ Department of Clinical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
² Department of Gastroenterology, Catholic University, School of Medicine and Surgery, A. Gemelli Hospital, Rome, Italy.

Comment

Stefano Bibbò et al. Mediators Inflamm. 2018.

. 2018 Aug 19:2018:7328057.

doi: 10.1155/2018/7328057. eCollection 2018.

¹ Department of Clinical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
² Department of Gastroenterology, Catholic University, School of Medicine and Surgery, A. Gemelli Hospital, Rome, Italy.

No abstract available

Comment on

Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease".
Li X, Yuan FL. Li X, et al. Mediators Inflamm. 2018 Jul 19;2018:3746509. doi: 10.1155/2018/3746509. eCollection 2018. Mediators Inflamm. 2018. PMID: 30116145 Free PMC article. No abstract available.

1. Li X., Yuan F. L. Comment on “Gut microbiota as a driver of inflammation in nonalcoholic fatty liver disease”. Mediators of Inflammation. 2018;2018:2. doi: 10.1155/2018/3746509.3746509 - DOI - PMC - PubMed
1. Bibbò S., Ianiro G., Dore M. P., et al. Gut microbiota as a driver of inflammation in nonalcoholic fatty liver disease. Mediators of Inflammation. 2018;2018:7. doi: 10.1155/2018/9321643.9321643 - DOI - PMC - PubMed
1. Kobyliak N., Abenavoli L., Mykhalchyshyn G., et al. A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial. Journal of Gastrointestinal and Liver Diseases. 2018;27(1):41–49. doi: 10.15403/jgld.2014.1121.271.kby. - DOI - PubMed
1. Manzhalii E., Virchenko O., Falalyeyeva T., Beregova T., Stremmel W. Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial. Journal of Digestive Diseases. 2017;18(12):698–703. doi: 10.1111/1751-2980.12561. - DOI - PubMed
1. Mofidi F., Poustchi H., Yari Z., et al. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial. British Journal of Nutrition. 2017;117(5):662–668. doi: 10.1017/S0007114517000204. - DOI - PubMed